Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Adverse events in different administration routes of Edaravone: A pharmacovigilance study based on the FDA adverse event reporting system

Fig 2

Analysis of differential risk signals for different administration routes of Edaravone.

(A)CI, confidence interval;(B)ROR, reporting odds ratio; (C)a, number of cases with suspected AEs associated with the target drug.

Fig 2

doi: https://doi.org/10.1371/journal.pone.0346797.g002